Of course! Often referred to as “hemoglobinopathy profiling,” the hemoglobin HPLC (High-Performance Liquid Chromatography) or Electrophoresis test is a specialized diagnostic instrument used to identify distinct forms of hemoglobin based on their varied structures or genetic variants. This test is essential for the diagnosis of hemoglobin diseases, which can seriously impair the body’s capacity to carry and distribute oxygen. These disorders include thalassemia, sickle cell disease, and other aberrant hemoglobin problems.
The addition of “health heart diagnostics” (HHD) to the hemoglobinopathy profiling definition emphasizes the method’s subtle but important connection to cardiovascular health. This test can identify disorders including sickle cell disease and thalassemia, which are characterized by hemoglobin abnormalities that can stress the circulatory system and cause anemia and other consequences. For example, persistent anemia linked to these conditions requires